The rapid growth of AI agents has made them one of the fastest-scaling software categories by 2026, with the global market expanding from $5.25 billion in 2024 to an estimated $7.84 billion in 2025 and projected to reach $52.62 billion by 2030. Within this landscape, Hippocratic AI stands out as a healthcare-focused company addressing critical workforce shortages through multi-agent AI systems designed to support patient engagement and clinical operations. Founded by Munjal Shah, Dr. Meenesh Bhimani, and product leader Vishal Parikh, the company was built on the premise that AI can meaningfully augment overstretched healthcare systems by automating routine patient interactions and operational workflows.
Hippocratic AI’s core technology, Polaris, is a multi-agent LLM constellation that manages tasks such as inbound patient calls, appointment scheduling, intake processing, follow-ups, billing inquiries, and escalation to human clinicians when necessary. The company has raised approximately $402 million in total funding and achieved unicorn status following a $126 million Series C round in November 2025 led by Avenir Growth, with participation from SV Angel and CapitalG, at a $3.5 billion valuation. This positioning highlights Hippocratic AI’s role as a specialized, safety-focused platform for scalable patient-facing automation within the broader enterprise adoption of AI agents.